Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity.
Ustyanovska Avtenyuk N, Choukrani G, Ammatuna E, Niki T, Cendrowicz E, Lourens HJ, Huls G, Wiersma VR, Bremer E. Ustyanovska Avtenyuk N, et al. Among authors: huls g. Biomedicines. 2021 Dec 29;10(1):66. doi: 10.3390/biomedicines10010066. Biomedicines. 2021. PMID: 35052746 Free PMC article.
CD20-selective inhibition of CD47-SIRPα "don't eat me" signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab.
van Bommel PE, He Y, Schepel I, Hendriks MAJM, Wiersma VR, van Ginkel RJ, van Meerten T, Ammatuna E, Huls G, Samplonius DF, Helfrich W, Bremer E. van Bommel PE, et al. Among authors: huls g. Oncoimmunology. 2017 Oct 31;7(2):e1386361. doi: 10.1080/2162402X.2017.1386361. eCollection 2018. Oncoimmunology. 2017. PMID: 29308308 Free PMC article.
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach.
de Jong MRW, Visser L, Huls G, Diepstra A, van Vugt M, Ammatuna E, van Rijn RS, Vellenga E, van den Berg A, Fehrmann RSN, van Meerten T. de Jong MRW, et al. Among authors: huls g. PLoS One. 2018 Feb 28;13(2):e0193098. doi: 10.1371/journal.pone.0193098. eCollection 2018. PLoS One. 2018. PMID: 29489886 Free PMC article.
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis.
He Y, Bouwstra R, Wiersma VR, de Jong M, Jan Lourens H, Fehrmann R, de Bruyn M, Ammatuna E, Huls G, van Meerten T, Bremer E. He Y, et al. Among authors: huls g. Nat Commun. 2019 Feb 1;10(1):533. doi: 10.1038/s41467-018-08013-z. Nat Commun. 2019. PMID: 30710089 Free PMC article.
Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients.
Hilberink J, Hazenberg C, van den Berg E, Mulder A, Schuringa JJ, van der Helm L, de Groot M, Choi G, de Bock GH, Vellenga E, Ammatuna E, Huls G. Hilberink J, et al. Among authors: huls g. Leuk Res. 2019 May;80:33-39. doi: 10.1016/j.leukres.2019.03.004. Epub 2019 Mar 18. Leuk Res. 2019. PMID: 30954622 Free article. Clinical Trial.
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL.
Bouwstra R, He Y, de Boer J, Kooistra H, Cendrowicz E, Fehrmann RSN, Ammatuna E, Zu Eulenburg C, Nijland M, Huls G, Bremer E, van Meerten T. Bouwstra R, et al. Among authors: huls g. Cancer Immunol Res. 2019 Oct;7(10):1663-1671. doi: 10.1158/2326-6066.CIR-18-0781. Epub 2019 Aug 13. Cancer Immunol Res. 2019. PMID: 31409608
201 results